| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | SPTBN5 DLG5 XIRP1 MRTFB KIF27 MYO5A SMC3 HAP1 MACO1 TTLL5 SYNE2 CGN CEP295 DIXDC1 CROCC ADCY8 MRTFA | 3.74e-06 | 1099 | 86 | 17 | GO:0008092 |
| GeneOntologyMolecularFunction | ATP-dependent activity | SMARCA5 ABCA1 DDX59 KIF27 EP400 MYO5A SMC3 ATAD3A SMC1A NAIP SMARCA1 MOV10 | 1.23e-05 | 614 | 86 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | actin binding | 3.98e-05 | 479 | 86 | 10 | GO:0003779 | |
| GeneOntologyMolecularFunction | mediator complex binding | 1.09e-04 | 4 | 86 | 2 | GO:0036033 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.18e-04 | 441 | 86 | 9 | GO:0016887 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 5.39e-04 | 37 | 86 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | helicase activity | 6.05e-04 | 158 | 86 | 5 | GO:0004386 | |
| GeneOntologyBiologicalProcess | microtubule-based process | AKAP9 KIF27 MYO5A SMC3 HAP1 SMC1A TTLL5 SDCCAG8 SYNE2 CGN NINL CEP295 FYCO1 CEP152 DIXDC1 LZTS2 CROCC ZMYND12 | 2.00e-07 | 1058 | 84 | 18 | GO:0007017 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | AKAP9 SMC3 SMC1A TTLL5 SDCCAG8 SYNE2 CGN NINL CEP295 CEP152 DIXDC1 LZTS2 CROCC ZMYND12 | 1.16e-06 | 720 | 84 | 14 | GO:0000226 |
| GeneOntologyBiologicalProcess | organelle assembly | IRGM XIRP1 KIF27 SMC3 HAP1 SMC1A TTLL5 SDCCAG8 SYNE2 CEP295 CEP152 ATM LZTS2 CROCC CCDC136 VPS13B ZMYND12 | 2.76e-06 | 1138 | 84 | 17 | GO:0070925 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | NPHP1 SPTBN5 IRGM DLG5 ABCA1 AKAP9 LZTS3 RHPN2 HAP1 SDCCAG8 SYNE2 CEP295 SRCIN1 ATM CGNL1 CROCC | 2.09e-05 | 1189 | 84 | 16 | GO:0044087 |
| GeneOntologyBiologicalProcess | establishment of meiotic sister chromatid cohesion | 9.78e-05 | 4 | 84 | 2 | GO:0034089 | |
| GeneOntologyBiologicalProcess | regulation of striated muscle tissue development | 1.40e-04 | 25 | 84 | 3 | GO:0016202 | |
| GeneOntologyBiologicalProcess | vesicle cytoskeletal trafficking | 1.61e-04 | 67 | 84 | 4 | GO:0099518 | |
| GeneOntologyBiologicalProcess | brain development | DLG5 MRTFB KIF27 HAP1 MACO1 SYNE2 SMARCA1 NCOA1 DIXDC1 ATM VPS13B MRTFA | 1.80e-04 | 859 | 84 | 12 | GO:0007420 |
| GeneOntologyBiologicalProcess | regulation of muscle organ development | 2.70e-04 | 31 | 84 | 3 | GO:0048634 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | SPTBN5 IRGM SMARCA5 AKAP9 MYO5A RHPN2 HAP1 SDCCAG8 SYNE2 CEP295 FYCO1 DIXDC1 ATM CGNL1 CROCC | 3.09e-04 | 1342 | 84 | 15 | GO:0033043 |
| GeneOntologyBiologicalProcess | actin filament-based process | NPHP1 SPTBN5 XIRP1 MRTFB AKAP9 MYO5A RHPN2 SYNE2 DIXDC1 SRCIN1 CGNL1 MRTFA | 3.12e-04 | 912 | 84 | 12 | GO:0030029 |
| GeneOntologyBiologicalProcess | head development | DLG5 MRTFB KIF27 HAP1 MACO1 SYNE2 SMARCA1 NCOA1 DIXDC1 ATM VPS13B MRTFA | 3.35e-04 | 919 | 84 | 12 | GO:0060322 |
| GeneOntologyBiologicalProcess | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity | 3.40e-04 | 7 | 84 | 2 | GO:0031585 | |
| GeneOntologyBiologicalProcess | regulation of skeletal muscle fiber differentiation | 3.40e-04 | 7 | 84 | 2 | GO:1902809 | |
| GeneOntologyBiologicalProcess | establishment of mitotic sister chromatid cohesion | 3.40e-04 | 7 | 84 | 2 | GO:0034087 | |
| GeneOntologyCellularComponent | actin cytoskeleton | SPTBN5 XIRP1 MYO5A HAP1 CGN RAI14 DIXDC1 SRCIN1 CGNL1 CROCC ADCY8 | 2.13e-05 | 576 | 85 | 11 | GO:0015629 |
| GeneOntologyCellularComponent | subapical part of cell | 4.89e-05 | 3 | 85 | 2 | GO:0120219 | |
| GeneOntologyCellularComponent | centriole | 7.26e-05 | 172 | 85 | 6 | GO:0005814 | |
| GeneOntologyCellularComponent | microtubule organizing center | TCP10L DLG5 AKAP9 HAP1 TTLL5 SDCCAG8 NINL CEP295 CEP152 ATM LZTS2 CROCC NEK9 | 8.26e-05 | 919 | 85 | 13 | GO:0005815 |
| GeneOntologyCellularComponent | centrosome | AKAP9 HAP1 TTLL5 SDCCAG8 NINL CEP295 CEP152 ATM LZTS2 CROCC NEK9 | 2.81e-04 | 770 | 85 | 11 | GO:0005813 |
| GeneOntologyCellularComponent | meiotic cohesin complex | 3.39e-04 | 7 | 85 | 2 | GO:0030893 | |
| GeneOntologyCellularComponent | mitotic cohesin complex | 3.39e-04 | 7 | 85 | 2 | GO:0030892 | |
| GeneOntologyCellularComponent | NURF complex | 3.39e-04 | 7 | 85 | 2 | GO:0016589 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 4.03e-04 | 153 | 85 | 5 | GO:0097731 | |
| GeneOntologyCellularComponent | anchoring junction | NPHP1 FBLN7 DLG5 XIRP1 SDCCAG8 SYNE2 CGN EVPL RAI14 DIXDC1 SRCIN1 CGNL1 | 5.69e-04 | 976 | 85 | 12 | GO:0070161 |
| GeneOntologyCellularComponent | mitotic spindle pole | 7.12e-04 | 43 | 85 | 3 | GO:0097431 | |
| GeneOntologyCellularComponent | cohesin complex | 8.78e-04 | 11 | 85 | 2 | GO:0008278 | |
| GeneOntologyCellularComponent | non-motile cilium | 1.23e-03 | 196 | 85 | 5 | GO:0097730 | |
| GeneOntologyCellularComponent | actomyosin | 1.33e-03 | 117 | 85 | 4 | GO:0042641 | |
| GeneOntologyCellularComponent | ISWI-type complex | 1.44e-03 | 14 | 85 | 2 | GO:0031010 | |
| GeneOntologyCellularComponent | myosin complex | 1.79e-03 | 59 | 85 | 3 | GO:0016459 | |
| Domain | tRNA-bd_arm | 7.30e-08 | 24 | 86 | 5 | IPR010978 | |
| Domain | P-loop_NTPase | IRGM DLG5 SMARCA5 ABCA1 DDX59 KIF27 EP400 MYO5A SMC3 ATAD3A SMC1A NAIP SMARCA1 URGCP ELP4 MOV10 | 1.39e-06 | 848 | 86 | 16 | IPR027417 |
| Domain | - | IRGM DLG5 SMARCA5 ABCA1 DDX59 EP400 SMC3 ATAD3A SMC1A NAIP SMARCA1 URGCP ELP4 MOV10 | 7.34e-06 | 746 | 86 | 14 | 3.40.50.300 |
| Domain | SLIDE | 2.10e-05 | 2 | 86 | 2 | IPR015195 | |
| Domain | ISWI_HAND-dom | 2.10e-05 | 2 | 86 | 2 | IPR015194 | |
| Domain | SLIDE | 2.10e-05 | 2 | 86 | 2 | PF09111 | |
| Domain | HAND | 2.10e-05 | 2 | 86 | 2 | PF09110 | |
| Domain | ISWI | 2.10e-05 | 2 | 86 | 2 | IPR029915 | |
| Domain | Hist_deacetylase_Gln_rich_N | 6.27e-05 | 3 | 86 | 2 | IPR024643 | |
| Domain | DBINO | 6.27e-05 | 3 | 86 | 2 | PF13892 | |
| Domain | HDAC4_Gln | 6.27e-05 | 3 | 86 | 2 | PF12203 | |
| Domain | DBINO | 6.27e-05 | 3 | 86 | 2 | IPR020838 | |
| Domain | Histone_deAcase_II_euk | 1.25e-04 | 4 | 86 | 2 | IPR017320 | |
| Domain | SMC | 2.08e-04 | 5 | 86 | 2 | IPR024704 | |
| Domain | CH | 2.29e-04 | 65 | 86 | 4 | SM00033 | |
| Domain | CH | 3.05e-04 | 70 | 86 | 4 | PF00307 | |
| Domain | SMC_hinge | 3.11e-04 | 6 | 86 | 2 | PF06470 | |
| Domain | SMC_hinge | 3.11e-04 | 6 | 86 | 2 | SM00968 | |
| Domain | SMC_hinge | 3.11e-04 | 6 | 86 | 2 | IPR010935 | |
| Domain | Spectrin_repeat | 3.16e-04 | 29 | 86 | 3 | IPR002017 | |
| Domain | - | 3.22e-04 | 71 | 86 | 4 | 1.10.418.10 | |
| Domain | CH | 3.58e-04 | 73 | 86 | 4 | PS50021 | |
| Domain | CH-domain | 3.97e-04 | 75 | 86 | 4 | IPR001715 | |
| Domain | SNF2_N | 4.25e-04 | 32 | 86 | 3 | IPR000330 | |
| Domain | Spectrin/alpha-actinin | 4.25e-04 | 32 | 86 | 3 | IPR018159 | |
| Domain | SNF2_N | 4.25e-04 | 32 | 86 | 3 | PF00176 | |
| Domain | SPEC | 4.25e-04 | 32 | 86 | 3 | SM00150 | |
| Domain | RPEL | 4.34e-04 | 7 | 86 | 2 | PS51073 | |
| Domain | RPEL | 4.34e-04 | 7 | 86 | 2 | PF02755 | |
| Domain | RPEL | 4.34e-04 | 7 | 86 | 2 | SM00707 | |
| Domain | RPEL_repeat | 4.34e-04 | 7 | 86 | 2 | IPR004018 | |
| Domain | RecF/RecN/SMC_N | 5.76e-04 | 8 | 86 | 2 | IPR003395 | |
| Domain | SMC_N | 5.76e-04 | 8 | 86 | 2 | PF02463 | |
| Domain | DEAH_ATP_HELICASE | 7.08e-04 | 38 | 86 | 3 | PS00690 | |
| Domain | - | 8.23e-04 | 40 | 86 | 3 | 4.10.1000.10 | |
| Domain | t-SNARE | 1.02e-03 | 43 | 86 | 3 | IPR010989 | |
| Domain | Hist_deacetyl | 1.12e-03 | 11 | 86 | 2 | PF00850 | |
| Domain | His_deacetylse_dom | 1.12e-03 | 11 | 86 | 2 | IPR023801 | |
| Domain | - | 1.12e-03 | 11 | 86 | 2 | 3.40.800.20 | |
| Domain | His_deacetylse | 1.12e-03 | 11 | 86 | 2 | IPR000286 | |
| Domain | GrpE_coiled_coil | 1.34e-03 | 12 | 86 | 2 | IPR013805 | |
| Domain | ZnF_C3H1 | 1.40e-03 | 48 | 86 | 3 | SM00356 | |
| Domain | zf-CCCH | 1.49e-03 | 49 | 86 | 3 | PF00642 | |
| Domain | Helicase_C | 1.51e-03 | 107 | 86 | 4 | PF00271 | |
| Domain | HELICc | 1.51e-03 | 107 | 86 | 4 | SM00490 | |
| Domain | Helicase_C | 1.56e-03 | 108 | 86 | 4 | IPR001650 | |
| Domain | SANT | 1.58e-03 | 50 | 86 | 3 | SM00717 | |
| Domain | HELICASE_CTER | 1.61e-03 | 109 | 86 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.61e-03 | 109 | 86 | 4 | PS51192 | |
| Domain | DEXDc | 1.61e-03 | 109 | 86 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.67e-03 | 110 | 86 | 4 | IPR014001 | |
| Domain | SANT/Myb | 1.77e-03 | 52 | 86 | 3 | IPR001005 | |
| Domain | Znf_CCCH | 2.42e-03 | 58 | 86 | 3 | IPR000571 | |
| Domain | ZF_C3H1 | 2.42e-03 | 58 | 86 | 3 | PS50103 | |
| Domain | Myosin_tail_1 | 3.06e-03 | 18 | 86 | 2 | PF01576 | |
| Domain | Myosin_tail | 3.06e-03 | 18 | 86 | 2 | IPR002928 | |
| Domain | - | 4.16e-03 | 21 | 86 | 2 | 1.10.720.30 | |
| Domain | EPHD | 4.56e-03 | 22 | 86 | 2 | PS51805 | |
| Domain | SAP | 4.56e-03 | 22 | 86 | 2 | PF02037 | |
| Pathway | WP_RETT_SYNDROME | 2.62e-06 | 48 | 65 | 5 | M39759 | |
| Pathway | WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME | 1.50e-05 | 11 | 65 | 3 | M42562 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 4.10e-05 | 204 | 65 | 7 | M4217 | |
| Pathway | REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE | 7.89e-05 | 96 | 65 | 5 | MM15207 | |
| Pathway | REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE | 8.29e-05 | 97 | 65 | 5 | M27478 | |
| Pathway | REACTOME_AURKA_ACTIVATION_BY_TPX2 | 3.17e-04 | 71 | 65 | 4 | MM15495 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 3.29e-04 | 202 | 65 | 6 | MM15362 | |
| Pathway | REACTOME_AURKA_ACTIVATION_BY_TPX2 | 3.35e-04 | 72 | 65 | 4 | M27749 | |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 4.91e-04 | 142 | 65 | 5 | M27233 | |
| Pathway | PID_ATM_PATHWAY | 5.06e-04 | 34 | 65 | 3 | M84 | |
| Pathway | REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES | 5.25e-04 | 81 | 65 | 4 | M748 | |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 6.30e-04 | 85 | 65 | 4 | MM14906 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 6.50e-04 | 37 | 65 | 3 | M29790 | |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 6.88e-04 | 87 | 65 | 4 | M27194 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COHESIN_LOADING | 7.38e-04 | 9 | 65 | 2 | M47868 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 7.81e-04 | 90 | 65 | 4 | MM14979 | |
| Pathway | REACTOME_COHESIN_LOADING_ONTO_CHROMATIN | 9.20e-04 | 10 | 65 | 2 | M27178 | |
| Pathway | REACTOME_COHESIN_LOADING_ONTO_CHROMATIN | 9.20e-04 | 10 | 65 | 2 | MM14892 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 9.57e-04 | 95 | 65 | 4 | M6729 | |
| Pathway | REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION | 1.12e-03 | 11 | 65 | 2 | M27177 | |
| Pathway | REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION | 1.12e-03 | 11 | 65 | 2 | MM14891 | |
| Pathway | REACTOME_CELL_CYCLE | 1.21e-03 | 694 | 65 | 10 | M543 | |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 1.23e-03 | 46 | 65 | 3 | MM14935 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 1.31e-03 | 47 | 65 | 3 | M29777 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.55e-03 | 272 | 65 | 6 | M29619 | |
| Pathway | WP_CILIOPATHIES | 1.57e-03 | 184 | 65 | 5 | M39880 | |
| Pathway | REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS | 1.58e-03 | 13 | 65 | 2 | M27661 | |
| Pathway | REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS | 1.58e-03 | 13 | 65 | 2 | MM15363 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 1.58e-03 | 13 | 65 | 2 | MM15622 | |
| Pathway | REACTOME_CELL_CYCLE | 1.70e-03 | 603 | 65 | 9 | MM14635 | |
| Pathway | WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION | 1.84e-03 | 14 | 65 | 2 | M39772 | |
| Pathway | REACTOME_M_PHASE | 1.97e-03 | 387 | 65 | 7 | MM15364 | |
| Pathway | WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM | 2.07e-03 | 55 | 65 | 3 | M39598 | |
| Pathway | REACTOME_MEIOSIS | 2.27e-03 | 120 | 65 | 4 | M529 | |
| Pathway | REACTOME_CILIUM_ASSEMBLY | 2.32e-03 | 201 | 65 | 5 | M27472 | |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | 2.42e-03 | 297 | 65 | 6 | M27050 | |
| Pubmed | PCF11 MRPL17 SOX5 RNF214 KMT2C FOXP4 SMARCA5 HDAC5 EP400 MYO5A SMC3 ATAD3A CNOT10 SMC1A SYNE2 MBNL1 SMARCA1 NCOA1 HIC2 RAI14 MSL1 CEP152 MOV10 FTSJ3 | 6.32e-14 | 1429 | 87 | 24 | 35140242 | |
| Pubmed | TBKBP1 HDAC5 LRCH2 CCDC186 MACO1 SMC1A SYNE2 CEP152 LZTS2 ELP4 | 7.87e-10 | 251 | 87 | 10 | 29778605 | |
| Pubmed | TBKBP1 HDAC5 AKAP9 LRCH2 SMC3 CNOT10 SMC1A CGN NINL CEP295 CEP152 LZTS2 | 1.27e-09 | 446 | 87 | 12 | 24255178 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | DLG5 MRTFB TBKBP1 MAST4 LRCH2 JADE3 MACO1 TTLL5 SDCCAG8 CGN NINL CEP295 CEP152 CGNL1 FTSJ3 | 3.16e-09 | 853 | 87 | 15 | 28718761 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | NPHP1 SART1 RNF214 TBKBP1 HDAC5 LRCH2 SMC3 CNOT10 SMC1A SDCCAG8 MBNL1 CGN NINL RAI14 EEA1 NEK9 URGCP MOV10 | 3.87e-09 | 1321 | 87 | 18 | 27173435 |
| Pubmed | KMT2C DLG5 MAST4 EP400 JADE3 NINL HIC2 RAI14 DIXDC1 SRCIN1 LZTS2 URGCP | 8.54e-09 | 529 | 87 | 12 | 14621295 | |
| Pubmed | Muscleblind-like proteins: similarities and differences in normal and myotonic dystrophy muscle. | 1.51e-08 | 3 | 87 | 3 | 19095965 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 11929853 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 15257297 | ||
| Pubmed | Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy. | 1.51e-08 | 3 | 87 | 3 | 28698297 | |
| Pubmed | Loss of MBNL1 induces RNA misprocessing in the thymus and peripheral blood. | 1.51e-08 | 3 | 87 | 3 | 32332745 | |
| Pubmed | Involvement of the cohesin protein, Smc1, in Atm-dependent and independent responses to DNA damage. | 1.51e-08 | 3 | 87 | 3 | 11877376 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 25263597 | ||
| Pubmed | 6.04e-08 | 4 | 87 | 3 | 26501102 | ||
| Pubmed | Developmental expression of mouse muscleblind genes Mbnl1, Mbnl2 and Mbnl3. | 6.04e-08 | 4 | 87 | 3 | 12915312 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | KMT2C FOXP4 MRTFB TBKBP1 MYO5A MBNL2 ATAD3A SDCCAG8 MBNL1 NAIP RAI14 BOD1L1 SRCIN1 LZTS2 CROCC NEK9 VPS13B | 1.44e-07 | 1489 | 87 | 17 | 28611215 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | PCF11 SART1 SMC3 ATAD3A CNOT10 SMC1A RAI14 MSL1 CEP152 DIXDC1 ATM EEA1 NEK9 VPS13B MOV10 | 1.69e-07 | 1155 | 87 | 15 | 20360068 |
| Pubmed | 2.15e-07 | 101 | 87 | 6 | 26949739 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 2.52e-07 | 351 | 87 | 9 | 38297188 | |
| Pubmed | MBNL and CELF proteins regulate alternative splicing of the skeletal muscle chloride channel CLCN1. | 3.01e-07 | 6 | 87 | 3 | 19720736 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | SART1 SLC25A22 DLG5 SMARCA5 MYO5A SMC3 ATAD3A SMC1A CGN SMARCA1 EVPL RAI14 LZTS2 MOV10 FTSJ3 | 4.95e-07 | 1257 | 87 | 15 | 36526897 |
| Pubmed | SART1 SMARCA5 MRTFB LRCH2 EP400 ATAD3A RAI14 BOD1L1 NEK9 MRTFA | 5.72e-07 | 506 | 87 | 10 | 30890647 | |
| Pubmed | A chromatin remodelling complex that loads cohesin onto human chromosomes. | 8.39e-07 | 8 | 87 | 3 | 12198550 | |
| Pubmed | TRIM29 regulates the assembly of DNA repair proteins into damaged chromatin. | 1.09e-06 | 31 | 87 | 4 | 26095369 | |
| Pubmed | 1.19e-06 | 549 | 87 | 10 | 38280479 | ||
| Pubmed | PCF11 STX8 DLG5 SMARCA5 AKAP9 EP400 CGN SMARCA1 RAI14 MSL1 EEA1 LZTS2 MBNL3 MOV10 FTSJ3 | 1.46e-06 | 1371 | 87 | 15 | 36244648 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SART1 FOXP4 SMARCA5 HDAC5 KIF27 EP400 SMC3 SMC1A SMARCA1 POU2F2 HIC2 MOV10 | 1.51e-06 | 857 | 87 | 12 | 25609649 |
| Pubmed | 1.63e-06 | 225 | 87 | 7 | 12168954 | ||
| Pubmed | 1.88e-06 | 146 | 87 | 6 | 21399614 | ||
| Pubmed | 2.05e-06 | 233 | 87 | 7 | 37704626 | ||
| Pubmed | Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. | 2.74e-06 | 87 | 87 | 5 | 17148452 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | TBKBP1 AKAP9 LRCH2 MYO5A MACO1 NINL FYCO1 NEK9 GOLGA3 MOV10 FTSJ3 | 2.90e-06 | 754 | 87 | 11 | 33060197 |
| Pubmed | 3.27e-06 | 12 | 87 | 3 | 37143315 | ||
| Pubmed | PCF11 MRPL17 STX8 DLG5 AKAP9 MYO5A ATAD3A MACO1 TTLL5 SYNE2 ATM LZTS2 VPS13B GOLGA3 FTSJ3 | 3.95e-06 | 1487 | 87 | 15 | 33957083 | |
| Pubmed | 4.14e-06 | 493 | 87 | 9 | 15368895 | ||
| Pubmed | 4.93e-06 | 98 | 87 | 5 | 34943047 | ||
| Pubmed | 4.98e-06 | 645 | 87 | 10 | 25281560 | ||
| Pubmed | SART1 TRIM67 AKAP9 LRCH2 LZTS3 MYO5A SYNE2 FYCO1 DIXDC1 NEK9 GOLGA3 LRRC15 | 5.00e-06 | 963 | 87 | 12 | 28671696 | |
| Pubmed | 6.00e-06 | 102 | 87 | 5 | 26584622 | ||
| Pubmed | Distal Alternative Last Exons Localize mRNAs to Neural Projections. | 6.19e-06 | 2 | 87 | 2 | 26907613 | |
| Pubmed | Compound loss of muscleblind-like function in myotonic dystrophy. | 6.19e-06 | 2 | 87 | 2 | 24293317 | |
| Pubmed | A quantitative model of the switch cycle of an archaeal flagellar motor and its sensory control. | 6.19e-06 | 2 | 87 | 2 | 16192281 | |
| Pubmed | MBNL Sequestration by Toxic RNAs and RNA Misprocessing in the Myotonic Dystrophy Brain. | 6.19e-06 | 2 | 87 | 2 | 26257173 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 28416514 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 29735517 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 17273969 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 31754023 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 29331264 | ||
| Pubmed | Mbnl1 and Mbnl2 regulate brain structural integrity in mice. | 6.19e-06 | 2 | 87 | 2 | 34848815 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 20098426 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 18442975 | ||
| Pubmed | A positively charged channel within the Smc1/Smc3 hinge required for sister chromatid cohesion. | 6.19e-06 | 2 | 87 | 2 | 21139566 | |
| Pubmed | Cornelia de Lange syndrome mutations in SMC1A or SMC3 affect binding to DNA. | 6.19e-06 | 2 | 87 | 2 | 18996922 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 21519849 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 17714703 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 15292197 | ||
| Pubmed | Myocardin related transcription factors are required for coordinated cell cycle progression. | 6.19e-06 | 2 | 87 | 2 | 23656782 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 35567413 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 28623279 | ||
| Pubmed | MBNL proteins repress ES-cell-specific alternative splicing and reprogramming. | 6.19e-06 | 2 | 87 | 2 | 23739326 | |
| Pubmed | Imbalance of SMC1 and SMC3 cohesins causes specific and distinct effects. | 6.19e-06 | 2 | 87 | 2 | 23776448 | |
| Pubmed | MRTF-A/B suppress the oncogenic properties of v-ras- and v-src-mediated transformants. | 6.19e-06 | 2 | 87 | 2 | 20338973 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 23853104 | ||
| Pubmed | Alternative splicing mediates the compensatory upregulation of MBNL2 upon MBNL1 loss-of-function. | 6.19e-06 | 2 | 87 | 2 | 36617982 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 29335431 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 26498848 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 12944485 | ||
| Pubmed | Studying the Effect of MBNL1 and MBNL2 Loss in Skeletal Muscle Regeneration. | 6.19e-06 | 2 | 87 | 2 | 38473933 | |
| Pubmed | Identification of a region in the coiled-coil domain of Smc3 that is essential for cohesin activity. | 6.19e-06 | 2 | 87 | 2 | 27307603 | |
| Pubmed | Ataxia telangiectasia mutated (ATM) interacts with p400 ATPase for an efficient DNA damage response. | 6.19e-06 | 2 | 87 | 2 | 27814680 | |
| Pubmed | Myocardin-related transcription factors are required for skeletal muscle development. | 6.19e-06 | 2 | 87 | 2 | 27385017 | |
| Pubmed | Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins. | 6.19e-06 | 2 | 87 | 2 | 22901804 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 24440524 | ||
| Pubmed | Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. | 6.19e-06 | 2 | 87 | 2 | 10970838 | |
| Pubmed | Myocardin-related transcription factors are required for cardiac development and function. | 6.19e-06 | 2 | 87 | 2 | 26386146 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 20009516 | ||
| Pubmed | Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. | 6.19e-06 | 2 | 87 | 2 | 17988634 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 36204878 | ||
| Pubmed | 6.73e-06 | 15 | 87 | 3 | 17925232 | ||
| Pubmed | 7.84e-06 | 187 | 87 | 6 | 26460568 | ||
| Pubmed | KMT2C XIRP1 AKAP9 LRCH2 LZTS3 CNOT10 CCDC186 SRCIN1 LZTS2 URGCP | 8.86e-06 | 689 | 87 | 10 | 36543142 | |
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | 1.03e-05 | 298 | 87 | 7 | 32353859 | |
| Pubmed | 1.17e-05 | 304 | 87 | 7 | 32235678 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 1.23e-05 | 565 | 87 | 9 | 25468996 | |
| Pubmed | PCF11 SART1 SLC25A22 SMARCA5 TRIM67 MYO5A ATAD3A SYNE2 SMARCA1 BOD1L1 CEP295 MSL1 ATM EEA1 | 1.33e-05 | 1442 | 87 | 14 | 35575683 | |
| Pubmed | 1.42e-05 | 19 | 87 | 3 | 25245017 | ||
| Pubmed | 1.48e-05 | 209 | 87 | 6 | 36779422 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 1.50e-05 | 440 | 87 | 8 | 34244565 | |
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 22139079 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 27063795 | ||
| Pubmed | Role of CRP2-MRTF interaction in functions of myofibroblasts. | 1.85e-05 | 3 | 87 | 2 | 37164693 | |
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 21738833 | ||
| Pubmed | Characterization of the components of the putative mammalian sister chromatid cohesion complex. | 1.85e-05 | 3 | 87 | 2 | 10375619 | |
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 17363709 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 11359880 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 26024305 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 23106691 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 11564881 | ||
| Pubmed | The tumor suppressor, TAX1BP2, is a novel substrate of ATM kinase. | 1.85e-05 | 3 | 87 | 2 | 24240686 | |
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 20358602 | ||
| Interaction | NDE1 interactions | 1.74e-09 | 117 | 86 | 9 | int:NDE1 | |
| Interaction | NDC80 interactions | SART1 DLG5 TRIM67 AKAP9 ANGPT4 SMC1A TTLL5 SYNE2 CEP295 CEP152 CCDC136 GOLGA3 | 8.44e-09 | 312 | 86 | 12 | int:NDC80 |
| Interaction | CEP135 interactions | DLG5 TBKBP1 AKAP9 LZTS3 MACO1 TTLL5 CGN CEP295 CEP152 CGNL1 LZTS2 | 2.21e-08 | 272 | 86 | 11 | int:CEP135 |
| Interaction | ANAPC2 interactions | DLG5 TRIM67 JADE3 CNOT10 MACO1 SMC1A NINL CEP152 LZTS2 GOLGA3 | 6.02e-08 | 234 | 86 | 10 | int:ANAPC2 |
| Interaction | NINL interactions | DLG5 MAST4 LZTS3 MYO5A JADE3 CNOT10 TTLL5 SDCCAG8 NINL CEP295 CEP152 CGNL1 LZTS2 | 7.01e-08 | 458 | 86 | 13 | int:NINL |
| Interaction | ATG16L1 interactions | STX8 IRGM DLG5 SMARCA5 TBKBP1 TRIM67 MYO5A SMC3 CNOT10 SMC1A TTLL5 MBNL1 CEP152 DIXDC1 ATM LZTS2 GOLGA3 MOV10 FTSJ3 | 3.31e-07 | 1161 | 86 | 19 | int:ATG16L1 |
| Interaction | KRT19 interactions | DLG5 TBKBP1 TRIM67 AKAP9 CNOT10 TTLL5 NINL CEP295 CEP152 LZTS2 | 3.41e-07 | 282 | 86 | 10 | int:KRT19 |
| Interaction | TRIM29 interactions | 6.25e-07 | 231 | 86 | 9 | int:TRIM29 | |
| Interaction | CEP85 interactions | 6.30e-07 | 169 | 86 | 8 | int:CEP85 | |
| Interaction | LHX2 interactions | 1.15e-06 | 183 | 86 | 8 | int:LHX2 | |
| Interaction | FOXJ2 interactions | 1.27e-06 | 81 | 86 | 6 | int:FOXJ2 | |
| Interaction | TEAD2 interactions | 1.39e-06 | 130 | 86 | 7 | int:TEAD2 | |
| Interaction | STIL interactions | 1.53e-06 | 190 | 86 | 8 | int:STIL | |
| Interaction | DYNLL2 interactions | 1.83e-06 | 263 | 86 | 9 | int:DYNLL2 | |
| Interaction | VPS33B interactions | 2.16e-06 | 199 | 86 | 8 | int:VPS33B | |
| Interaction | PCM1 interactions | DLG5 TRIM67 HDAC5 AKAP9 HAP1 CNOT10 TTLL5 NINL CEP295 CEP152 EEA1 | 2.33e-06 | 434 | 86 | 11 | int:PCM1 |
| Interaction | SEPTIN10 interactions | 2.76e-06 | 144 | 86 | 7 | int:SEPTIN10 | |
| Interaction | TNRC6A interactions | 3.06e-06 | 280 | 86 | 9 | int:TNRC6A | |
| Interaction | HDAC1 interactions | HDAC9 SMARCA5 MRTFB TRIM67 HDAC5 AKAP9 EP400 SMC3 SMC1A SYNE2 RAI14 ATM CROCC NEK9 GOLGA3 MRTFA FTSJ3 | 3.69e-06 | 1108 | 86 | 17 | int:HDAC1 |
| Interaction | CIITA interactions | 3.70e-06 | 55 | 86 | 5 | int:CIITA | |
| Interaction | CEP250 interactions | 3.75e-06 | 287 | 86 | 9 | int:CEP250 | |
| Interaction | BMI1 interactions | DLG5 SMARCA5 TRIM67 AKAP9 MBNL2 HSF2BP EVPL ATM CGNL1 EEA1 MOV10 ENOX2 FTSJ3 | 4.21e-06 | 659 | 86 | 13 | int:BMI1 |
| Interaction | SASS6 interactions | 5.31e-06 | 159 | 86 | 7 | int:SASS6 | |
| Interaction | SP7 interactions | 5.97e-06 | 304 | 86 | 9 | int:SP7 | |
| Interaction | ALB interactions | 6.43e-06 | 391 | 86 | 10 | int:ALB | |
| Interaction | CNOT9 interactions | 6.49e-06 | 231 | 86 | 8 | int:CNOT9 | |
| Interaction | RAB9A interactions | STX8 TRIM67 MYO5A SMC3 MACO1 SMC1A SYNE2 FYCO1 EEA1 VPS13B GOLGA3 FTSJ3 | 8.19e-06 | 595 | 86 | 12 | int:RAB9A |
| Interaction | CEP170 interactions | 8.58e-06 | 318 | 86 | 9 | int:CEP170 | |
| Interaction | SMC2 interactions | 9.72e-06 | 323 | 86 | 9 | int:SMC2 | |
| Interaction | PATL1 interactions | 1.07e-05 | 177 | 86 | 7 | int:PATL1 | |
| Interaction | CEP152 interactions | 1.15e-05 | 179 | 86 | 7 | int:CEP152 | |
| Interaction | WHAMMP3 interactions | 1.19e-05 | 119 | 86 | 6 | int:WHAMMP3 | |
| Interaction | FOXP2 interactions | 1.22e-05 | 70 | 86 | 5 | int:FOXP2 | |
| Interaction | VPS33A interactions | 1.26e-05 | 253 | 86 | 8 | int:VPS33A | |
| Interaction | BAG2 interactions | NPHP1 RNF214 MRTFB TRIM67 HDAC5 MBNL1 NINL BOD1L1 URGCP VPS13B MBNL3 MRTFA | 1.28e-05 | 622 | 86 | 12 | int:BAG2 |
| Interaction | SAMD4B interactions | 1.38e-05 | 122 | 86 | 6 | int:SAMD4B | |
| Interaction | ANAPC13 interactions | 1.41e-05 | 72 | 86 | 5 | int:ANAPC13 | |
| Interaction | SNW1 interactions | PCF11 SART1 SMARCA5 TRIM67 KIF27 SMC3 SMC1A HSF2BP NCOA1 MSL1 ATM LZTS2 FTSJ3 | 1.61e-05 | 747 | 86 | 13 | int:SNW1 |
| Interaction | SYCE1 interactions | 1.73e-05 | 127 | 86 | 6 | int:SYCE1 | |
| Interaction | CEP192 interactions | 1.82e-05 | 192 | 86 | 7 | int:CEP192 | |
| Interaction | SYNE3 interactions | DLG5 TBKBP1 TRIM67 CNOT10 MACO1 SYNE2 CEP295 CEP152 CGNL1 LZTS2 | 1.93e-05 | 444 | 86 | 10 | int:SYNE3 |
| Interaction | STX6 interactions | 2.09e-05 | 448 | 86 | 10 | int:STX6 | |
| Interaction | FEV interactions | 2.60e-05 | 203 | 86 | 7 | int:FEV | |
| Interaction | TNRC6B interactions | 2.75e-05 | 282 | 86 | 8 | int:TNRC6B | |
| Interaction | GSK3A interactions | SART1 DLG5 SMARCA5 TRIM67 MAST4 AKAP9 LRCH2 CEP152 LZTS2 GOLGA3 | 2.82e-05 | 464 | 86 | 10 | int:GSK3A |
| Interaction | SMG5 interactions | 2.98e-05 | 84 | 86 | 5 | int:SMG5 | |
| Interaction | CFH interactions | 3.01e-05 | 140 | 86 | 6 | int:CFH | |
| Interaction | PPP1R18 interactions | 3.13e-05 | 141 | 86 | 6 | int:PPP1R18 | |
| Interaction | KLF15 interactions | 3.35e-05 | 290 | 86 | 8 | int:KLF15 | |
| Interaction | PKN1 interactions | 3.66e-05 | 145 | 86 | 6 | int:PKN1 | |
| Interaction | ACTC1 interactions | SART1 SMARCA5 MRTFB TRIM67 LRCH2 EP400 ATAD3A SYNE2 RAI14 BOD1L1 NEK9 MRTFA | 3.75e-05 | 694 | 86 | 12 | int:ACTC1 |
| Interaction | ELF5 interactions | 3.96e-05 | 147 | 86 | 6 | int:ELF5 | |
| Interaction | MBNL3 interactions | 4.04e-05 | 16 | 86 | 3 | int:MBNL3 | |
| Interaction | RASSF8 interactions | 4.39e-05 | 91 | 86 | 5 | int:RASSF8 | |
| Interaction | CGNL1 interactions | 4.40e-05 | 46 | 86 | 4 | int:CGNL1 | |
| Interaction | RAB5A interactions | STX8 SMARCA5 TRIM67 MACO1 SYNE2 MBNL1 SMARCA1 RAI14 EEA1 VPS13B GOLGA3 MOV10 | 4.43e-05 | 706 | 86 | 12 | int:RAB5A |
| Interaction | RCOR1 interactions | SOX5 SMARCA5 MRTFB TRIM67 HDAC5 NINL RAI14 NEK9 GOLGA3 MRTFA | 4.78e-05 | 494 | 86 | 10 | int:RCOR1 |
| Interaction | FOXG1 interactions | 5.39e-05 | 95 | 86 | 5 | int:FOXG1 | |
| Interaction | BAZ1A interactions | 5.51e-05 | 156 | 86 | 6 | int:BAZ1A | |
| Interaction | GNL3L interactions | 5.71e-05 | 157 | 86 | 6 | int:GNL3L | |
| Interaction | YWHAH interactions | DLG5 TRIM67 MAST4 HDAC5 AKAP9 LRCH2 RHPN2 SYNE2 CGN NINL NCOA1 RAI14 BOD1L1 CEP152 CGNL1 | 5.98e-05 | 1102 | 86 | 15 | int:YWHAH |
| Interaction | SUPT5H interactions | 6.08e-05 | 408 | 86 | 9 | int:SUPT5H | |
| Interaction | SMC3 interactions | 6.08e-05 | 408 | 86 | 9 | int:SMC3 | |
| Interaction | PFN1 interactions | DLG5 TRIM67 HDAC5 AKAP9 MYO5A SYNE2 BOD1L1 CEP152 GOLGA3 MRTFA | 6.14e-05 | 509 | 86 | 10 | int:PFN1 |
| Interaction | DYNLL1 interactions | RNF214 KMT2C DLG5 TRIM67 AKAP9 MYO5A CEP152 ATM NEK9 CCDC136 | 6.24e-05 | 510 | 86 | 10 | int:DYNLL1 |
| Interaction | LZTS2 interactions | 6.45e-05 | 512 | 86 | 10 | int:LZTS2 | |
| Interaction | ACAD11 interactions | 6.57e-05 | 161 | 86 | 6 | int:ACAD11 | |
| Interaction | ANKFY1 interactions | 6.77e-05 | 236 | 86 | 7 | int:ANKFY1 | |
| Interaction | NUP43 interactions | MRTFB TRIM67 EP400 JADE3 SMC1A SYNE2 SMARCA1 BOD1L1 MSL1 ELP4 FTSJ3 | 6.94e-05 | 625 | 86 | 11 | int:NUP43 |
| Interaction | NDEL1 interactions | 7.28e-05 | 164 | 86 | 6 | int:NDEL1 | |
| Interaction | HMGA1 interactions | 7.45e-05 | 419 | 86 | 9 | int:HMGA1 | |
| Interaction | FYCO1 interactions | 7.93e-05 | 103 | 86 | 5 | int:FYCO1 | |
| Interaction | RNF214 interactions | 8.30e-05 | 104 | 86 | 5 | int:RNF214 | |
| Interaction | VPS45 interactions | 8.32e-05 | 168 | 86 | 6 | int:VPS45 | |
| Interaction | SOX2 interactions | SOX5 KMT2C DLG5 FOXP4 SMARCA5 EP400 SMC3 ATAD3A MACO1 SMC1A EVPL RAI14 BOD1L1 MSL1 LZTS2 ENOX2 FTSJ3 | 9.10e-05 | 1422 | 86 | 17 | int:SOX2 |
| Interaction | EGR2 interactions | 9.17e-05 | 171 | 86 | 6 | int:EGR2 | |
| Interaction | CBX8 interactions | 9.47e-05 | 249 | 86 | 7 | int:CBX8 | |
| Interaction | GIT1 interactions | 9.47e-05 | 172 | 86 | 6 | int:GIT1 | |
| Interaction | KRT38 interactions | 9.47e-05 | 172 | 86 | 6 | int:KRT38 | |
| Interaction | MKI67 interactions | MRPL17 HDAC9 FOXP4 TRIM67 EP400 SMC3 ATAD3A CNOT10 SMC1A MOV10 FTSJ3 | 9.57e-05 | 648 | 86 | 11 | int:MKI67 |
| Interaction | MRTFB interactions | 1.03e-04 | 57 | 86 | 4 | int:MRTFB | |
| Interaction | DLG5 interactions | 1.07e-04 | 176 | 86 | 6 | int:DLG5 | |
| Interaction | EED interactions | SART1 SLC25A22 SMARCA5 TRIM67 EP400 RHPN2 SMC3 SMC1A CGN SMARCA1 RAI14 CGNL1 LZTS2 CROCC NEK9 MOV10 FTSJ3 | 1.11e-04 | 1445 | 86 | 17 | int:EED |
| Interaction | STX7 interactions | STX8 DLG5 TRIM67 MYO5A MACO1 SYNE2 RAI14 EEA1 LZTS2 ADCY8 GOLGA3 | 1.11e-04 | 659 | 86 | 11 | int:STX7 |
| Interaction | CEP63 interactions | 1.18e-04 | 179 | 86 | 6 | int:CEP63 | |
| Interaction | RBM14 interactions | PCF11 HDAC9 SMARCA5 TBKBP1 TRIM67 HDAC5 AKAP9 SMC1A MOV10 FTSJ3 | 1.22e-04 | 553 | 86 | 10 | int:RBM14 |
| Interaction | YWHAZ interactions | HDAC9 DLG5 TRIM67 MAST4 HDAC5 AKAP9 MYO5A MACO1 SMC1A SYNE2 CGN RAI14 ATM CGNL1 GOLGA3 MOV10 | 1.28e-04 | 1319 | 86 | 16 | int:YWHAZ |
| Interaction | CLIP1 interactions | 1.33e-04 | 183 | 86 | 6 | int:CLIP1 | |
| Interaction | ARHGEF4 interactions | 1.34e-04 | 61 | 86 | 4 | int:ARHGEF4 | |
| Interaction | PDLIM7 interactions | 1.36e-04 | 264 | 86 | 7 | int:PDLIM7 | |
| Interaction | KAT5 interactions | 1.46e-04 | 358 | 86 | 8 | int:KAT5 | |
| Interaction | FAM9C interactions | 1.52e-04 | 63 | 86 | 4 | int:FAM9C | |
| Interaction | SMARCA4 interactions | 1.56e-04 | 462 | 86 | 9 | int:SMARCA4 | |
| Interaction | CEP43 interactions | 1.63e-04 | 190 | 86 | 6 | int:CEP43 | |
| Interaction | KDM1A interactions | DLG5 SMARCA5 MRTFB TRIM67 HDAC5 AKAP9 EP400 RAI14 FYCO1 CEP152 NEK9 GOLGA3 MRTFA | 1.70e-04 | 941 | 86 | 13 | int:KDM1A |
| Interaction | ZNF648 interactions | 1.72e-04 | 65 | 86 | 4 | int:ZNF648 | |
| Interaction | DDX59 interactions | 1.82e-04 | 26 | 86 | 3 | int:DDX59 | |
| Interaction | AVEN interactions | 1.82e-04 | 26 | 86 | 3 | int:AVEN | |
| Interaction | DNMBP interactions | 1.90e-04 | 124 | 86 | 5 | int:DNMBP | |
| Interaction | FOXL1 interactions | 1.93e-04 | 196 | 86 | 6 | int:FOXL1 | |
| Cytoband | 15q21 | 1.93e-04 | 11 | 87 | 2 | 15q21 | |
| GeneFamily | Leucine zipper tumor suppressor family | 5.43e-05 | 4 | 55 | 2 | 1314 | |
| GeneFamily | Histone deacetylases, class IIA | 5.43e-05 | 4 | 55 | 2 | 992 | |
| GeneFamily | Zinc fingers CCCH-type | 1.63e-04 | 35 | 55 | 3 | 73 | |
| GeneFamily | Structural maintenance of chromosomes proteins|Cohesin complex | 1.89e-04 | 7 | 55 | 2 | 761 | |
| GeneFamily | Cohesin complex | 2.51e-04 | 8 | 55 | 2 | 1060 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 5.60e-04 | 53 | 55 | 3 | 532 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 3.99e-03 | 31 | 55 | 2 | 81 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | SLC25A22 TRIM67 MAST4 AKAP9 LZTS3 MYO5A CCDC186 MACO1 CGN NINL POU2F2 BOD1L1 SRCIN1 EEA1 GOLGA3 | 2.86e-06 | 1106 | 86 | 15 | M39071 |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP | 3.58e-06 | 194 | 86 | 7 | M8019 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_DN | 3.96e-06 | 197 | 86 | 7 | M9916 | |
| Coexpression | GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN | 2.97e-05 | 181 | 86 | 6 | M8662 | |
| Coexpression | GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP | 4.90e-05 | 198 | 86 | 6 | M4249 | |
| Coexpression | GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN | 5.04e-05 | 199 | 86 | 6 | M9498 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN | 5.04e-05 | 199 | 86 | 6 | M6519 | |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN | 5.18e-05 | 200 | 86 | 6 | M8306 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | SOX5 RNF214 SMARCA5 DDX59 AKAP9 LRCH2 MYO5A SMC3 SMC1A SYNE2 BOD1L1 CEP295 FYCO1 ATM ENOX2 FTSJ3 | 5.55e-06 | 1060 | 87 | 16 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 3.06e-05 | 298 | 87 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | SMARCA5 MRTFB AKAP9 MYO5A SMC3 SMC1A SYNE2 NINL BOD1L1 CEP295 EEA1 GOLGA3 MRTFA | 3.24e-05 | 831 | 87 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.15e-05 | 311 | 87 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | SOX5 FOXP4 SMARCA5 ABCA1 AKAP9 SMC3 JADE3 HAP1 SMC1A SYNE2 NINL NCOA1 ATM MBNL3 | 4.51e-05 | 986 | 87 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | SOX5 SMARCA5 DDX59 AKAP9 LRCH2 MYO5A SMC3 SMC1A SYNE2 NINL HIC2 BOD1L1 CEP295 DIXDC1 ATM FTSJ3 | 4.54e-05 | 1257 | 87 | 16 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | SOX5 RNF214 SMARCA5 DDX59 AKAP9 LRCH2 MYO5A SMC3 SMC1A SYNE2 CGN BOD1L1 CEP295 FYCO1 ATM ENOX2 FTSJ3 | 5.19e-05 | 1414 | 87 | 17 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.67e-05 | 168 | 87 | 6 | gudmap_developingGonad_P2_ovary_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | SOX5 SMARCA5 ABCA1 AKAP9 SMC3 JADE3 HAP1 SMC1A SDCCAG8 SYNE2 NINL NCOA1 CCDC136 | 6.76e-05 | 893 | 87 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | SOX5 HDAC9 KMT2C SMARCA5 MAST4 MYO5A JADE3 SYNE2 HSF2BP CEP295 ATM MBNL3 | 7.48e-05 | 776 | 87 | 12 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | SOX5 HDAC9 KMT2C SMARCA5 MAST4 MYO5A SYNE2 CGN HSF2BP CEP295 EEA1 MBNL3 | 7.67e-05 | 778 | 87 | 12 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | SOX5 FOXP4 SMARCA5 DDX59 AKAP9 MYO5A SMC3 JADE3 HAP1 SMC1A SYNE2 NINL HIC2 BOD1L1 CEP295 ATM | 1.25e-04 | 1370 | 87 | 16 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.39e-04 | 192 | 87 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | SOX5 SMARCA5 AKAP9 LRCH2 SMC3 HAP1 CCDC186 SMC1A SYNE2 MBNL1 BOD1L1 CEP295 FYCO1 DIXDC1 ATM | 1.59e-04 | 1252 | 87 | 15 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | 1.73e-04 | 382 | 87 | 8 | gudmap_developingGonad_e14.5_ ovary_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | SMARCA5 AKAP9 RHPN2 SMC3 JADE3 HAP1 CCDC186 SMC1A SYNE2 NINL BOD1L1 CEP295 DIXDC1 | 1.87e-04 | 989 | 87 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | SOX5 SMARCA5 DDX59 AKAP9 LRCH2 MYO5A SMC3 SMC1A SYNE2 NINL HIC2 BOD1L1 CEP295 DIXDC1 ATM FTSJ3 | 2.57e-04 | 1459 | 87 | 16 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#4 | 3.19e-04 | 316 | 87 | 7 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | DDX59 MRTFB MAST4 AKAP9 CCDC186 SMC1A TTLL5 SYNE2 SMARCA1 EEA1 GOLGA3 | 3.37e-04 | 780 | 87 | 11 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.68e-04 | 230 | 87 | 6 | gudmap_developingGonad_e18.5_ovary_1000_k5 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-08 | 178 | 87 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 1.29e-07 | 199 | 87 | 7 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.29e-07 | 199 | 87 | 7 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 1.29e-07 | 199 | 87 | 7 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.34e-07 | 200 | 87 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 2.25e-06 | 194 | 87 | 6 | 8dcde77767b23e75360adb316cdccf56a00e3726 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 2.53e-06 | 198 | 87 | 6 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 2.60e-06 | 199 | 87 | 6 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 2.60e-06 | 199 | 87 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 2.60e-06 | 199 | 87 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 2.60e-06 | 199 | 87 | 6 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 6.85e-06 | 135 | 87 | 5 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 7.62e-06 | 138 | 87 | 5 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.42e-05 | 157 | 87 | 5 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | Nasal_Brush-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.21e-05 | 172 | 87 | 5 | 58eaadf12366701103a0d1f133462c9495fedc30 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-05 | 177 | 87 | 5 | 1dc69c661e70e7e22bd9d7cf953eb638da9fd43c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.97e-05 | 183 | 87 | 5 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-05 | 183 | 87 | 5 | 8de4b616a06be03e1cb6ae6a9ce6bf06485629d3 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-05 | 187 | 87 | 5 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-05 | 188 | 87 | 5 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.56e-05 | 190 | 87 | 5 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.65e-05 | 191 | 87 | 5 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.83e-05 | 193 | 87 | 5 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.83e-05 | 193 | 87 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.93e-05 | 194 | 87 | 5 | 48c37251518f96524807b5bd1bbc2820637666ad | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.93e-05 | 194 | 87 | 5 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.93e-05 | 194 | 87 | 5 | 7b6a34d1f8922b71dcc931421666c1822cec8345 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4|GI_small-bowel / Manually curated celltypes from each tissue | 3.93e-05 | 194 | 87 | 5 | 4547b57669be5d4f0de55175802ee04372288a6a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.93e-05 | 194 | 87 | 5 | 1dce6d4b6ac41f80677e3e4c335a4f383bd76f85 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.93e-05 | 194 | 87 | 5 | 435406ebe626c702f7d5a99a3d68ee85aa09be95 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.02e-05 | 195 | 87 | 5 | 42bfdff88da1d07828c0ad65d412fb1752f0cee4 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 195 | 87 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 195 | 87 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.02e-05 | 195 | 87 | 5 | 34a9462f4e843f3065cc58c17ad71c1b5b836ae1 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.22e-05 | 197 | 87 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.22e-05 | 197 | 87 | 5 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4|GI_small-bowel / Manually curated celltypes from each tissue | 4.33e-05 | 198 | 87 | 5 | 6333e46cd1ccf5841ce15aea98a4b2f5e3ae4675 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 4.33e-05 | 198 | 87 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 4.43e-05 | 199 | 87 | 5 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / Treatment groups by lineage, cell group, cell type | 4.54e-05 | 200 | 87 | 5 | b036f5e22c95a3b14391785b6e91aa183b9bc9a8 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.54e-05 | 200 | 87 | 5 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.54e-05 | 200 | 87 | 5 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Control-B_activate-7|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.65e-05 | 115 | 87 | 4 | cc2f8fb0cbb72b241b65a69195aac0507bddf2e2 | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 132 | 87 | 4 | 4152529611eeacf0c547e2a134d5b98c45426b13 | |
| ToppCell | Control-Treg|World / Disease group and Cell class | 2.79e-04 | 161 | 87 | 4 | ead9f5a491321f9e307f7c97e47a4ca124f59bb6 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-ABC_aged-B_naive|bone_marrow / Manually curated celltypes from each tissue | 2.86e-04 | 162 | 87 | 4 | 44832055b11a789e320c802aadb345e065defc8f | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-04 | 166 | 87 | 4 | 91eeb48680dd07ae4115afacdc0a8f6fa18885e5 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-04 | 166 | 87 | 4 | 43f84d3cd58e93ce00c241656c4cba27604b4932 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.28e-04 | 168 | 87 | 4 | 8072d0496b7b730c4601009eaa69ec5366d26d73 | |
| ToppCell | Control-B_cells-Activated_B_cells|Control / group, cell type (main and fine annotations) | 3.28e-04 | 168 | 87 | 4 | a7159a35fe37f8c241cf8d391debe271e0698105 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.35e-04 | 169 | 87 | 4 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-Tuft|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.35e-04 | 169 | 87 | 4 | 05e12524d68d409fed386ffad233305683b4575b | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.43e-04 | 170 | 87 | 4 | 6ec0cf055ae55e9fac147f7989c47f83ab07270c | |
| ToppCell | Influenza_Severe-gd_T|Influenza_Severe / Disease group and Cell class | 3.43e-04 | 170 | 87 | 4 | 59009c5a504ea8c6b4f6697299db219fd5edf7d6 | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.43e-04 | 170 | 87 | 4 | e421f9eedf74baffda1d03707a710ece4b777f29 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.51e-04 | 171 | 87 | 4 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.51e-04 | 171 | 87 | 4 | 2b7c5a557c4bc5c573211c4d618bdd6766a24916 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.51e-04 | 171 | 87 | 4 | dcb15bc54aeea06ef8f07f1134f3ff1e21ac0e4f | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.59e-04 | 172 | 87 | 4 | c96bd3407911df3e3e6d7a3dba786b11814b9598 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_1|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.59e-04 | 172 | 87 | 4 | 4483073469001770015526303772fd54906c5d68 | |
| ToppCell | (07)_Ionocytes-(2)_GFP_FOXI1|(07)_Ionocytes / shred by cell type by condition | 3.59e-04 | 172 | 87 | 4 | 5776b638b845d054f6e884e7df0412477f48517d | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-04 | 177 | 87 | 4 | 426a9845df7fd13b02e744532c336c60bc4d4a22 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.17e-04 | 179 | 87 | 4 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.17e-04 | 179 | 87 | 4 | a28a1de500a74c6dcc43481abf9ec0f7e7a300a9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.26e-04 | 180 | 87 | 4 | 8f774dcacc1626e4e6492f1eb927b0ed56fbe686 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-Treg|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.35e-04 | 181 | 87 | 4 | a6c8b33a392de3df2f179317e329e45d3d8c6f52 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 4.35e-04 | 181 | 87 | 4 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.35e-04 | 181 | 87 | 4 | 8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86 | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-04 | 182 | 87 | 4 | 398ce074a04f6482470b488f1affae4af7d2ec58 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.53e-04 | 183 | 87 | 4 | 121791ef84e7ce377ed6f5b7953af8865e04958e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.53e-04 | 183 | 87 | 4 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.53e-04 | 183 | 87 | 4 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | nucseq-Immune-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.62e-04 | 184 | 87 | 4 | 911658e7bb499c1bbc8419eec8ff88729bc39a75 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.62e-04 | 184 | 87 | 4 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.62e-04 | 184 | 87 | 4 | 942b58ae7172bb5f97e55b032db9329d161854af | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 4.72e-04 | 185 | 87 | 4 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.72e-04 | 185 | 87 | 4 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.72e-04 | 185 | 87 | 4 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.82e-04 | 186 | 87 | 4 | 77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.82e-04 | 186 | 87 | 4 | d7d884ff4184636081c350d29f797bd923c6a3b4 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.82e-04 | 186 | 87 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.82e-04 | 186 | 87 | 4 | 13bc41c60fd628af31899a5e8b480e06cc4781be | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.91e-04 | 187 | 87 | 4 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.91e-04 | 187 | 87 | 4 | f5a202d5f8eb57b57d80815ce98774e04c387383 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.01e-04 | 188 | 87 | 4 | 72cbfe9dc0583dbeafa6cb0945fa370d0c808284 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.01e-04 | 188 | 87 | 4 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.12e-04 | 189 | 87 | 4 | 06c44746fa4f02e6e2b3b635cdf2d8dfef3754d3 | |
| ToppCell | COVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.12e-04 | 189 | 87 | 4 | 2586f4088721c5debec86c2b211b739fd33713eb | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-04 | 190 | 87 | 4 | 36e83995021ba16690f84e2077a9e8baec547d05 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.22e-04 | 190 | 87 | 4 | d19bc44310c53726e2f5f6a2bd377bbbf1d1983f | |
| ToppCell | NS-critical-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.22e-04 | 190 | 87 | 4 | 7be0f2ff86ca8500a43e0d44e5e292530f9ba0bb | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.22e-04 | 190 | 87 | 4 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.22e-04 | 190 | 87 | 4 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.22e-04 | 190 | 87 | 4 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-04 | 190 | 87 | 4 | d26be9e1b676f750e716b91ebc3598fac3735612 | |
| ToppCell | COPD-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 5.22e-04 | 190 | 87 | 4 | 1e85ee686ff6dd27c69415d524d54fa825b1daad | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.22e-04 | 190 | 87 | 4 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.22e-04 | 190 | 87 | 4 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.32e-04 | 191 | 87 | 4 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.32e-04 | 191 | 87 | 4 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| Drug | Guanadrel sulfate [22195-34-2]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 8.54e-07 | 196 | 87 | 8 | 4720_UP | |
| Drug | Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; MCF7; HT_HG-U133A | 8.88e-07 | 197 | 87 | 8 | 6105_DN | |
| Drug | Amidopyrine [58-15-1]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 8.88e-07 | 197 | 87 | 8 | 2222_UP | |
| Drug | Melatonin [73-31-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 9.22e-07 | 198 | 87 | 8 | 5393_DN | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; HL60; HT_HG-U133A | 9.95e-07 | 200 | 87 | 8 | 2677_DN | |
| Drug | Sparteine (-) [90-39-1]; Down 200; 17uM; MCF7; HT_HG-U133A | 8.11e-06 | 189 | 87 | 7 | 2790_DN | |
| Drug | Baclofen (R,S) [1134-47-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A | 1.03e-05 | 196 | 87 | 7 | 1536_UP | |
| Drug | Nadolol [42200-33-9]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.03e-05 | 196 | 87 | 7 | 3359_DN | |
| Drug | Sulfinpyrazone [57-96-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.03e-05 | 196 | 87 | 7 | 3192_DN | |
| Drug | Triprolidine hydrochloride [550-70-9]; Down 200; 12.8uM; HL60; HT_HG-U133A | 1.06e-05 | 197 | 87 | 7 | 2376_DN | |
| Drug | Dyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; HL60; HT_HG-U133A | 1.10e-05 | 198 | 87 | 7 | 2392_DN | |
| Drug | Tetrahydrozoline hydrochloride [522-48-5]; Down 200; 16.8uM; MCF7; HT_HG-U133A | 1.13e-05 | 199 | 87 | 7 | 6069_DN | |
| Drug | clofarabine | 6.82e-05 | 21 | 87 | 3 | ctd:C068329 | |
| Drug | Ethaverine hydrochloride [985-13-7]; Up 200; 9.2uM; PC3; HT_HG-U133A | 7.31e-05 | 183 | 87 | 6 | 6737_UP | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 7.54e-05 | 184 | 87 | 6 | 1007_UP | |
| Drug | Dikar | 8.62e-05 | 4 | 87 | 2 | CID006433517 | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 9.26e-05 | 191 | 87 | 6 | 4168_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 9.53e-05 | 192 | 87 | 6 | 5567_UP | |
| Drug | Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 9.53e-05 | 192 | 87 | 6 | 6054_DN | |
| Drug | Cetirizine dihydrochloride [83881-52-1]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 9.80e-05 | 193 | 87 | 6 | 2829_UP | |
| Drug | Equilin [474-86-2]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.01e-04 | 194 | 87 | 6 | 3377_DN | |
| Drug | Felodipine [72509-76-3]; Down 200; 10.4uM; HL60; HT_HG-U133A | 1.01e-04 | 194 | 87 | 6 | 2433_DN | |
| Drug | Metronidazole [443-48-1]; Down 200; 23.4uM; MCF7; HT_HG-U133A | 1.01e-04 | 194 | 87 | 6 | 4141_DN | |
| Drug | Trimeprazine tartrate [4330-99-8]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 1.04e-04 | 195 | 87 | 6 | 3478_UP | |
| Drug | Gabapentin [60142-96-3]; Up 200; 23.4uM; MCF7; HT_HG-U133A | 1.04e-04 | 195 | 87 | 6 | 3472_UP | |
| Drug | Glipizide [29094-61-9]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.04e-04 | 195 | 87 | 6 | 4991_UP | |
| Drug | Nifurtimox [23256-30-6]; Up 200; 14uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 87 | 6 | 7328_UP | |
| Drug | Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 87 | 6 | 6260_UP | |
| Drug | Sulfadimethoxine [122-11-2]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 87 | 6 | 3441_UP | |
| Drug | F0447-0125; Down 200; 10uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 87 | 6 | 6396_DN | |
| Drug | Bergenin monohydrate [477-90-7]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 87 | 6 | 3467_UP | |
| Drug | Fluocinonide [356-12-7]; Down 200; 8uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 87 | 6 | 3933_DN | |
| Drug | Cefuroxime sodium salt [56238-63-2]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 87 | 6 | 6261_UP | |
| Drug | LY 294002; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.10e-04 | 197 | 87 | 6 | 6175_DN | |
| Drug | Hesperetin [520-33-2]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 87 | 6 | 5350_DN | |
| Drug | Iobenguane sulfate; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.13e-04 | 198 | 87 | 6 | 2878_UP | |
| Drug | Ifenprodil tartrate [23210-58-4]; Up 200; 8.4uM; HL60; HT_HG-U133A | 1.13e-04 | 198 | 87 | 6 | 2372_UP | |
| Drug | Nizatidine [76963-41-2]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.13e-04 | 198 | 87 | 6 | 5406_UP | |
| Drug | Loracarbef [121961-22-6]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.13e-04 | 198 | 87 | 6 | 5492_UP | |
| Drug | Monocrotaline [315-22-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.13e-04 | 198 | 87 | 6 | 2749_DN | |
| Drug | Finasteride [98319-26-7]; Up 200; 10.8uM; HL60; HT_HG-U133A | 1.13e-04 | 198 | 87 | 6 | 2206_UP | |
| Drug | Aminohippuric acid [61-78-9]; Down 200; 20.6uM; PC3; HT_HG-U133A | 1.13e-04 | 198 | 87 | 6 | 6294_DN | |
| Drug | Glycopyrrolate [596-51-0]; Down 200; 10uM; PC3; HT_HG-U133A | 1.13e-04 | 198 | 87 | 6 | 3687_DN | |
| Drug | PHA-00745360 [351320-33-7]; Up 200; 1uM; PC3; HT_HG-U133A | 1.13e-04 | 198 | 87 | 6 | 4562_UP | |
| Drug | Bicuculline (+) [485-49-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.13e-04 | 198 | 87 | 6 | 4397_DN | |
| Drug | Verapamyl hydrochloride [152-11-4]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 1.13e-04 | 198 | 87 | 6 | 5387_UP | |
| Drug | Dacarbazine [4342-03-4]; Up 200; 22uM; MCF7; HT_HG-U133A | 1.16e-04 | 199 | 87 | 6 | 6816_UP | |
| Drug | Rauwolscine hydrochloride [6211-32-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.16e-04 | 199 | 87 | 6 | 2778_DN | |
| Drug | Zomepirac sodium salt [64092-48-4]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.16e-04 | 199 | 87 | 6 | 6815_UP | |
| Drug | Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; PC3; HT_HG-U133A | 1.16e-04 | 199 | 87 | 6 | 7140_DN | |
| Drug | Trolox [53188-07-1]; Down 200; 16uM; MCF7; HT_HG-U133A | 1.16e-04 | 199 | 87 | 6 | 2883_DN | |
| Drug | Sulfanilamide [63-74-1]; Up 200; 23.2uM; HL60; HT_HG-U133A | 1.16e-04 | 199 | 87 | 6 | 2709_UP | |
| Drug | estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A | 1.16e-04 | 199 | 87 | 6 | 5601_DN | |
| Drug | Dihydrostreptomycin sulfate [5490-27-7]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 1.16e-04 | 199 | 87 | 6 | 2237_DN | |
| Drug | Benzocaine [94-09-7]; Up 200; 24.2uM; HL60; HT_HG-U133A | 1.19e-04 | 200 | 87 | 6 | 2167_UP | |
| Drug | Cyclopenthiazide [742-20-1]; Down 200; 10.6uM; HL60; HT_HG-U133A | 1.19e-04 | 200 | 87 | 6 | 2905_DN | |
| Drug | Fipexide hydrochloride [34161-23-4]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 1.19e-04 | 200 | 87 | 6 | 3176_UP | |
| Drug | ms-27 | 1.43e-04 | 5 | 87 | 2 | CID016122504 | |
| Drug | anacardic acid | 2.03e-04 | 30 | 87 | 3 | CID000167551 | |
| Disease | myotonic disease (implicated_via_orthology) | 2.15e-08 | 3 | 83 | 3 | DOID:450 (implicated_via_orthology) | |
| Disease | myotonic dystrophy type 2 (implicated_via_orthology) | 2.14e-07 | 5 | 83 | 3 | DOID:0050759 (implicated_via_orthology) | |
| Disease | myotonic dystrophy type 1 (implicated_via_orthology) | 4.27e-07 | 6 | 83 | 3 | DOID:11722 (implicated_via_orthology) | |
| Disease | Congenital muscular hypertrophy-cerebral syndrome | 7.77e-05 | 5 | 83 | 2 | C1802395 | |
| Disease | Cornelia de Lange Syndrome 3 | 7.77e-05 | 5 | 83 | 2 | C1853099 | |
| Disease | Cornelia de Lange Syndrome 1 | 7.77e-05 | 5 | 83 | 2 | C4551851 | |
| Disease | Cornelia de Lange syndrome (implicated_via_orthology) | 1.16e-04 | 6 | 83 | 2 | DOID:11725 (implicated_via_orthology) | |
| Disease | De Lange syndrome | 1.16e-04 | 6 | 83 | 2 | cv:C0270972 | |
| Disease | Renal dysplasia and retinal aplasia | 1.63e-04 | 7 | 83 | 2 | cv:C0403553 | |
| Disease | Senior-Loken syndrome (is_implicated_in) | 1.63e-04 | 7 | 83 | 2 | DOID:0050576 (is_implicated_in) | |
| Disease | Cornelia De Lange Syndrome | 2.16e-04 | 8 | 83 | 2 | C0270972 | |
| Disease | nephronophthisis (implicated_via_orthology) | 2.78e-04 | 9 | 83 | 2 | DOID:12712 (implicated_via_orthology) | |
| Disease | susceptibility to common cold measurement | 4.80e-04 | 54 | 83 | 3 | EFO_0008417 | |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 5.07e-04 | 12 | 83 | 2 | C0403553 | |
| Disease | Bardet-Biedl Syndrome | 5.98e-04 | 13 | 83 | 2 | C0752166 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 6.54e-04 | 60 | 83 | 3 | C4722327 | |
| Disease | Malignant neoplasm of breast | 8.58e-04 | 1074 | 83 | 10 | C0006142 | |
| Disease | central nervous system disease (implicated_via_orthology) | 9.14e-04 | 16 | 83 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | Prostate cancer, familial | 9.84e-04 | 69 | 83 | 3 | C2931456 | |
| Disease | sexual dimorphism measurement | 1.07e-03 | 1106 | 83 | 10 | EFO_0021796 | |
| Disease | Myeloid Leukemia | 1.16e-03 | 18 | 83 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 1.16e-03 | 18 | 83 | 2 | C0023466 | |
| Disease | visual cortical surface area measurement | 1.44e-03 | 20 | 83 | 2 | EFO_0004771 | |
| Disease | hair colour measurement | 1.75e-03 | 615 | 83 | 7 | EFO_0007822 | |
| Disease | macula measurement | 2.02e-03 | 189 | 83 | 4 | EFO_0008375 | |
| Disease | HDL cholesterol change measurement | 2.07e-03 | 24 | 83 | 2 | EFO_0007805 | |
| Disease | Neurodevelopmental Disorders | 2.32e-03 | 93 | 83 | 3 | C1535926 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RNIIQQLKNQVLFLL | 536 | Q13075 | |
| VLGLVQSLNRQRQKQ | 1196 | P40145 | |
| IIQGQLVQQQQVLQG | 271 | Q96L91 | |
| QIGQKQLQQIERQLK | 26 | P0DKL9 | |
| RRAQQEQLLLQKQLQ | 271 | Q9Y2D5 | |
| SQKQRNLQLNLLLEQ | 3251 | Q99996 | |
| NLQLNLLLEQQKQLL | 3256 | Q99996 | |
| LQEQLQRGKQEIENL | 546 | Q7Z3E2 | |
| ILLLKNEIQVLQQQN | 621 | O94986 | |
| DQLKQQQLLNEENLR | 191 | Q9NVI7 | |
| NLQGIKDALQQRLTQ | 366 | Q155Q3 | |
| LNVINNAILRANLQK | 1606 | O95477 | |
| IQQLQEILQDLQKRL | 431 | Q9P0K7 | |
| QQLLSAIRQLQQLLK | 31 | Q53RD9 | |
| ILQQQQQKKIAGRQE | 2391 | Q8NEZ4 | |
| KQQSLQRQLEQLRGL | 126 | Q9BW11 | |
| QLQVFQLQQEKRQLQ | 391 | Q9BRK4 | |
| QQGLQLQVLRLQQDK | 386 | O60299 | |
| LQQENLQIFTQLQKL | 916 | Q8TD19 | |
| QNVVGRNQLLEGKLQ | 626 | Q9BQS8 | |
| QLLQIRENVLENLQK | 161 | A1A4Y4 | |
| EQQLKLLQQALQGMQ | 451 | Q16206 | |
| QIENLKQQLGILVQG | 181 | Q5T1V6 | |
| RQLEIAQGQILQKDQ | 591 | Q8N5G2 | |
| NRLQNEKIIEQQLLV | 531 | Q86VH2 | |
| ALERQKQQQTLQLQE | 1601 | Q92817 | |
| LAKTRLQNQQNGQRV | 31 | Q9H936 | |
| ARLLQQQQLFLQLQI | 316 | Q9ULH7 | |
| QKEIGDLRAQQQQVL | 276 | Q8TDM6 | |
| GDIQQLLQLQQLVLV | 101 | P09086 | |
| NPQLNLKNVQRNLIL | 546 | Q9UL01 | |
| ALGNKQLAFQQQLLQ | 171 | Q8IVH2 | |
| LLLQLDLIEQQQQQL | 226 | Q68DK7 | |
| QQLEQVKLTLLQRDQ | 696 | Q08378 | |
| KNLTQEQLIRQQLLA | 196 | O94913 | |
| NQLRNNIRQQVLKSG | 111 | Q8NFC6 | |
| NRNQIGNQNKLIQEL | 1066 | Q15075 | |
| QVNLLIQQAIDPKNL | 3031 | Q13315 | |
| QQRQAQLVQRLQGKI | 166 | Q5TZA2 | |
| LQRQLQLEVKNQQNI | 626 | Q0VF96 | |
| QQEVARLQAQVLKLQ | 381 | P54257 | |
| KLENQLLLQRQKLQQ | 176 | Q9Y264 | |
| LLLQRQKLQQLQGQN | 181 | Q9Y264 | |
| KTQLEINGRNNLIQQ | 76 | Q9NR56 | |
| KTQLEINGRNNLIQQ | 76 | Q5VZF2 | |
| LKTQLEINGRNNLIQ | 76 | Q9NUK0 | |
| INKQNLILRNQIQQA | 601 | O15021 | |
| NALQLREKLGNIRNQ | 1456 | A4D0S4 | |
| QKKQRNILRIGIQNL | 246 | Q96EB1 | |
| LQQELLALKQQQQLQ | 76 | Q9UQL6 | |
| VREKQLQQELLLIQQ | 41 | Q9UKV0 | |
| LLIQQQQQIQKQLLI | 51 | Q9UKV0 | |
| LLVQRQTALQQQIQK | 1731 | Q9C0D2 | |
| KIQEQIFGLQVQLLN | 501 | Q92613 | |
| LKQNQENQGALQALL | 691 | O15259 | |
| IAAQLLQQEQKNRIL | 476 | Q5VUJ6 | |
| QLLLQLNQQRTKGFL | 31 | Q96JB3 | |
| ALRQQLNEAKQQLLQ | 101 | O75031 | |
| QLQQENRQLLNERIK | 806 | Q9UQE7 | |
| VIQQGRLIDQQSNKL | 646 | P28370 | |
| NQIKSQLQQPLLINL | 3166 | Q8WXH0 | |
| QQQIIRLHQELGRQK | 51 | Q8TDR4 | |
| VNLQELALQQNQIGL | 221 | Q8TF66 | |
| AKLDLQQGQNLLQGL | 951 | Q9HCE1 | |
| QVVVLENEGLQQQLK | 151 | Q86SQ7 | |
| PNQLRLQLQQRLQGQ | 1051 | Q15788 | |
| ENRRKGRQQQQKQQL | 556 | Q8IY81 | |
| GQQQSDQIQKLRVEL | 1191 | Q9Y2I6 | |
| LQNQRAALNQQILKA | 36 | Q8IUC4 | |
| KILQQQQLFLQLQIL | 261 | Q969V6 | |
| QGLLKQVQEQVAQRA | 1081 | Q9NRC6 | |
| QQQELQREGQRLLQG | 2736 | Q9NRC6 | |
| QAKQELLQQEQGRLL | 696 | Q96JN2 | |
| EQNLQLQKTLQQLRQ | 681 | Q9P2M7 | |
| LQNGNTQLALQIIKR | 691 | Q9H9A5 | |
| ENQLQVQLKQLQQRR | 251 | Q8ND24 | |
| LLENIRNGLSNQNKN | 906 | Q8TCY9 | |
| NQNKNIQQLIELVRR | 916 | Q8TCY9 | |
| QLKNILQQIQENGLD | 371 | Q6ZTA4 | |
| GQLQQLRKLQLQNQE | 666 | Q9C0H9 | |
| LQQKLNEQQSVLQRI | 1006 | Q14683 | |
| RQQQQKIIQEQDAGL | 141 | Q9UNK0 | |
| QLQQLQQLRDSGEKV | 511 | O43290 | |
| EERQHGLQQLQQRQK | 71 | Q9H0C1 | |
| LLLLQQQGQLQQQLL | 241 | P0CG23 | |
| QQEQRQLQLKLQEEL | 351 | P0CG23 | |
| LIIKVQQLNGVQKQI | 2711 | Q7Z7G8 | |
| QQLNGVQKQIIICGR | 2716 | Q7Z7G8 | |
| KINLLQQQIQVQGQL | 261 | P35711 | |
| VIQQGRLVDQNLNKI | 631 | O60264 | |
| QICGLEQQLRQQQGL | 161 | A7MCY6 | |
| RNQKELQGLLNQVQA | 1466 | Q702N8 | |
| ALQQLEQQKLQSRQL | 1151 | Q6EMB2 | |
| NQLLQGLRQDLRQSQ | 146 | Q9NRX2 | |
| IQSLKEENNRQQQLL | 1371 | Q9Y4I1 |